| abstract |
This invention relates to a controlled release, intravaginal, pharmaceutical dosage form. The dosage form consists of at least one desired pharmaceutically active ingredient which is admixed with a combination of biocompatible and biodegradable polymers and shaped for insertion into the vagina of a patient. The polymers are selected so as to biodegrade at a predetermined rate and, on biodegrading, the pharmaceutically active ingredient is released. |